India, May 14 -- image credit- freepik

Chennai-based Archimedis Digital, a life sciences-focused technology company, is strengthening its focus on advanced artificial intelligence (AI)-led innovation with a committed investment of $2 million. These investments are directed at accelerating AI-first scientific solutions and products, including but not limited to histopathology and cancer diagnosis.

The investment aligns with the growing demand for intelligent systems that can improve speed, accuracy, and predictability across the life sciences value chain.

As part of this broader push, Archimedis Digital is deepening its engagement with industry and academic ecosystems to expand its innovation capabilities. The company's association with...